ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 949,82
0,35%
DAX
17 932,17
-1,10%
Brent Oil
83,845
-2,39%
Bitcoin
56 861,70
-6,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) Actualités

HROW Harrow Inc

10,32
0,13 (1,28%)
Dernière mise à jour : 17:31:46
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Harrow Inc HROW NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,13 1,28% 10,32 17:31:46
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,24 10,04 10,44 10,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00BWHarrow Will Release First Quarter 2024 Financial Results..
02/4/202414:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
20/3/202412:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
19/3/202422:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
06/3/202412:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202413:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
22/2/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:15EDGAR2Form 8-K - Current report
15/2/202422:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
09/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202413:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202422:30EDGAR2Form 8-K - Current report
29/1/202421:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/1/202413:00BWHarrow Announces New Appointments to its Board of Directors
11/1/202413:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
09/1/202416:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202414:00EDGAR2Form 8-K - Current report
03/1/202413:15BWMelt Pharmaceuticals Provides Corporate Update
03/1/202413:00BWHarrow Partners with Leading Healthcare Market Access..
29/11/202313:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
20/11/202313:00BWHarrow to Present at Two Investor Conferences in November
16/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:34EDGAR2Form 8-K - Current report
13/11/202322:01BWHarrow Announces Third Quarter 2023 Financial Results
03/11/202321:52EDGAR2Form 8-K - Current report
30/10/202313:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
24/10/202313:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
29/9/202322:01EDGAR2Form 8-K - Current report
29/9/202314:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
26/9/202314:00BWMelt Pharmaceuticals Announces Exclusive Development and..
21/9/202300:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202313:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:01BWHarrow Announces Second Quarter 2023 Financial Results
31/7/202313:00BWHarrow Launches VIGAMOX® in the U.S.
26/7/202315:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
21/7/202322:02EDGAR2Form 8-K - Current report
21/7/202301:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/7/202301:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202323:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/7/202313:00BWHarrow Prices $60 Million Public Offering of Common Stock
19/7/202304:55BWHarrow erwirbt US-amerikanische und kanadische..
18/7/202323:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/7/202323:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
18/7/202322:59EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
HROW
Harrow
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés